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Purpose: The purpose of the study was to evaluate the activity of 50 % hydroalcohol flower extract of 
Nerium oleander Linn. on the central nervous system (CNS) of mice. 
Methods: The effect of the 50 % hydroalcohol extract of N. oleander flowers at dosage levels of 100 
and 200 mg/kg p.o. on the locomotor activity of mice was measured with an actophotometer while 
muscle relaxant activity was evaluated on rotarod apparatus. Also, the anticonvulsant activity of the 
extract in mice (following maximal electroshock and pentyleneterazol-induced convulsion) as well as the 
potentiation of pentobarbital-induced sleep were determined using standard procedures. Diazepam was 
used as the reference standard. 
Result: The extract (at doses of 100 and 200 mg/kg) significantly reduced (p < 0.01) spontaneous 
locomotor activity and also potentiated pentobarbital-induced sleep. At the higher dose (200 mg/kg) the 
extract showed 66 % protection against electroshock-induced convulsions while the lower dose (100 
mg/kg) produced a significant reduction (p < 0.01) in pentylenetetrazol (PTZ)-induced convulsions. 
Conclusion: The ethanol extract of Nerium oleander flowers has anticonvulsant activity in an 
experimental animal model. 
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INTRODUCTION 
 
Nerium oleander Linn. (Kaner) belongs to the 
family Apocynaceae. It is a large glabrous 
evergreen shrub that produces milky juice. It 
is native to Iran, the Mediterranean region, as 
well as India. The leaves are in pairs of three, 
shortly stalked, coriaceous, 10 - 15 cm long, 
linear lanceolate with dark green colour. The 
flowers are salver-shaped pink or white 
without any fragrance [1].  
 
In the traditional medicine system, parts of 
this plant are used for the treatment of 
various human ailments. The leaf is used as 
a cardiotonic, diuretic, anti-bacterial in 
cutaneous eruptions, and is also effective 
against snake-bites; the root is used for 
curing different types of cancers, ulcers and 
leprosy. The root-bark is used specifically 
against ring worm and the aqueous extracts 
of the leaves, branches, roots and flowers are 
toxic to certain insects [2]. Several 
phytochemicals have been identified in 
various parts of the plant and they include 
mainly cardiotonic glycosides, terpenoids and 
steroids [1]. 
 
A recent study has established that the hot 
aqueous extract of N. oleander leaves 
(Anvirzel) inhibits fibroblast growth factor-2 
and also has anti-tumor activity [3]. Another 
study demonstrated that the leaf extract has 
antibacterial and sedative-hypnotic activities 
and also affects behavioral pattern in mice 
[4]. The dried and fresh flowers of the plant 
have been reported to exhibit potent 
antiinflammatory activity against carrageenan 
hind paw edema model in mice without 
inducing any gastric damage [5].  
 
Although the leaves and the root have been 
the subject of several studies, there has been 
little investigation of the flowers. The 
objective of this study, therefore, was to 
investigate the anticonvulsant activities of the 






Drugs, chemicals and equipment  
 
Diazepam (Sigma Aldrich) was used as a 
standard CNS depressant and 
anticonvulsant. Pentylenetetrazol and 
pentobarbital (both from Sigma Aldrich), 
ethanol (Changshu Yangyuan Chemicals) 
China, petroleum ether (40 – 60 °C, Merck), 
rotary evaporator (Heidolph Schwabach, 
Germany), freeze dryer (Vis Tis Advantage, 
2.0 EL-85), actophotometer (Imcorp,Ambala, 
India), rotarod (model KI 9616, Ambala, 
India), electroconvulsiometer (Inco, Ambala, 
India), and grinding mill (Philips- HL1606 
Gurgaon, India ) were also used in the study. 
 
Plant material  
 
N. oleander flowers were collected from Kota 
district of Rajasthan in India. The flowers 
were authenticated by Dr SN Sharma, 
taxonomist, Botany Division, Indian Institute 
of Intregrative Medicine (IIIM), Jammu, India. 
A voucher specimen (CDR accession no. 
21869) was deposited at the crude drug 
repository of the herbarium of IIIM. 
 
Preparation of extract 
 
The flowers (2 kg) were shade-dried and 
coarsely powdered with a grinding mill. The 
powder was extracted with petroleum ether 
(40 – 60 ºC) to defat it and then macerated 
with ethanol:water (1:1) with constant stirring 
(1200 rpm, 3 h). The solvent incorporating 
the extractives was filtered and the marc 
pressed to squeeze out residual extractives. 
This process was repeated thrice to achieve 
complete extraction. The extracts obtained 
during the three cycles were combined and 
reduced to 1/8
th
 of its original volume in a 
rotary evaporator at 45 °C and then 
lyophilized in a freeze dryer to obtain a yield 
of 11 %w/w.  
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Animals 
 
Male Swiss albino mice (8 - 12 weeks old) 
weighing 18 - 20 g were purchased from the 
Central Animal House, IMTECH, Chandigarh, 
55/1999/ CPCSEA. The animal study 
protocol was approved by the Institution 
Animals Ethics Committee (IAEC) of 
ASBASJSM College of Pharmacy, Bela 
(Ropar) Punjab (approval no. 
ASCB/IAEC/02/10/005). The animals were 
housed under standard laboratory conditions 
(23 ± 1 °C, and 55 ± 10 %RH, 12/12 h 
light/dark cycle) and fed with standard pellet 
diet (M/s Ashirwad Industries, Mohali) and 
purified water ad libitum.  
 
Acute toxicity study 
 
Determination of maximum tolerable dose 
was performed according to OECD 
(Organization for Economic Corporation and 
Development) guideline 423 (11) [6]. The 
study was performed at graded doses of 5, 
50, 300 and 2000 mg/kg p.o. using 3 female 
mice (18 – 22 g) at each dose level. The mice 
were deprived of food 3 - 4 h prior to the 
experiment and thereafter individually 
administered the extract. Each animal was 
continuously monitored during the first 30 
min, then on hourly basis for the next 4 h, 
and subsequently, at four hourly interval. 
Finally, they were placed under observation 
for 14 days to monitor any abnormal signs 
and symptoms depicting toxicity. The animals 
were then humanely killed  by a high 
inhalation dose of diethyl ether and observed 
for any changes in skin and fur, eyes, 
mucous membrane (ear), respiratory, 
circulatory, autonomic and central nervous 
systems, a swell as somatosensory activity 
and behavioral pattern. Attention was given 
to phenomena such as tremors, convulsions, 
salivation, diarrhoea, lethargy, sedation, 
hypnosis and coma [6].  
 
Assessment of spontaneous motor 
activity 
 
The animals were divided into four groups of 
6 mice each. Group I served as control and 
received normal saline (1 ml/100 g body 
weight); Group II received the reference 
standard (diazepam, 2 mg/kg i.p.) while 
Groups III and IV received 100 and 200 
mg/kg p.o. of the extract, respectively. To 
evaluate spontaneous motor activity, each 
mouse was introduced into an 
actophotometer and its score of locomotor 
was measured after a period of 10 min [7]. 
 
Potentiation of pentobarbital-induced 
hypnosis 
 
The animals (excluding those used in the 
preceding experiment) were divided into 
three groups (n = 6). Group I was 
administered pentobarbital (50 mg/kg, i.p.); 
Groups II and III received 100 and 200 mg/kg 
of the extract orally, respectively, and then 
were injected with pentobarbital (50 mg/kg, 
i.p.) 2 h later. The time elapsed between loss 
and recovery of the righting reflex was noted 
and taken as sleeping time [8]. 
 
Evaluation of muscle relaxant activity 
 
Before performing this experiment, the fresh 
mice were trained to remain on rotarod 
apparatus (with the rod rotating at a speed of 
25 rpm) for 3 min. After training, the mice 
were divided into three groups (n = 6). Group 
I served as control, Group II as reference 
standard (diazepam, 4 mg/kg i.p.) while 
Groups III and IV were administered the 
extract (100 and 200 mg/kg p.o., 
respectively).  The effect on motor 
coordination was assessed with the rotarod 
apparatus as the fall-off time from the rotarod 
[7].   
 




Four groups of mice (n = 10) were used. 
Group I was administered the vehicle, i.e., 
normal saline (1 ml/100g body weight) and 
served as control, Group II received 
reference standard (diazepam, 2 mg/kg, i.p.) 
while Groups III and IV were administered 
100 and 200 mg/kg, p.o., respectively, of the 
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extract. Two hours later, PTZ was 
administered (60 mg/kg, i.p.) to all four 
groups. The animals were observed for 30 
min and the onset and duration of convulsion 
noted [8]. 
 
Maximum electroshock convulsion test 
 
Four groups of mice were used in this test. 
Group I ingested normal saline (1 ml/100 g) 
and served as control; Group II received the 
reference drug (diazepam, 2mg/kg, i.p.) while 
Groups III and IV were administered the 
extract (100 and 200 mg/kg, p.o., 
respectively. Two hours later, they were 
given a current of 12 mA 50 Hz for 0.2 sec in 
an electroconvulsiometer via an ear 
electrode. The onset of convulsion and 
duration of tonus were noted. Complete 
protection (100 %) against convulsion is 
achieved only when hind limb tonic extension 




All the data obtained were analyzed using 
one way analysis of variance (ANOVA) 
followed by Dunnett’s test or Student ‘t’ test 
(Graph-pad Prism statistical software). P < 




Acute toxicity of extract 
 
The maximum tolerable dose of the extract 
via oral administration was 2000 mg/kg body 
weight. 
 
Extract effect on spontaneous motor 
activity 
 
Table 1 shows the effect of the extract on 
spontaneous locomotor activity. Compared 
with the control group, a small but significant 
reduction (p < 0.05) in locomotor activity was 
observed after 1 h. However, much higher 
reduction in locomotor activity by the 
reference standard, diazepam, was found. 
Both the extract and standard effected very 
drastic reduction (p < 0.001) in locomotor 
activity after 2 and 3 h, respectively. 
 
Potentiation of pentobarbital-induced 
hypnosis 
 
Pentobarbital did not modify the latency to 
induce sleep after extract administration. 
However, as Fig 1 shows, the former 
increased the duration of extract-induced 
hypnosis significantly (p < 0.05 and p < 
0.001) at doses of 100 and 200 mg/kg, 
respectively. 
 
Fig 1: Potentiating of N. oleander flower extract-
induced hypnosis by pentobarbital in mice. Key: 
PB (50) = pentobarbital 50 mg/kg, i.p.; NO (100) = 
extract 100 mg/kg; NO (200) = extract 100 mg/kg 





p < 0.01  
 





0 h 1h 2 h 3 h 
Vehicle 198.7 ± 3.3 209.3 ± 4.0 205.3 ± 4.8 208.5 ± 4.2 
Diazepam 195.5 ± 3.0 10.2 ± 2.7† 24.2 ± 2.2† 26.12± 2.8† 
NO (100 mg/kg) 202.3 ± 3.6 194.0 ± 4.3# 28.3 ± 4.4† 22.7 ± 4.0† 
NO (200 mg/kg)  203.0 ± 3.9 193.0 ± 10.1# 33.5 ± 2.6† 29.3 ± 4.4† 
Statistically significant at 
#
p < 0.05 or, 
†
p  < .001 
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Muscle relaxant activity of extract 
 
The animals did not show any motor 
uncoordination after administration of the 
extract. 
 
Effect of extract on pentylenetetrazol-
induced convulsions 
 
Table 2 shows that the extract increased the 
onset of pentylenetetrazol-induced seizures 
but reduced the duration of the convulsions. 
The increase in the onset of seizure was 
statistically significant, p < 0.01) and p < 
0.05) for extract doses of 100 and 200 mg/kg, 
respectively, and highly significant (p < 
0.001) for the standard drug, diazepam; with 
regard to their duration reduction effect, the 
difference was statistically significant at p < 
0.01 for both doses. However, the clonus 
phase was completely abolished only at the 
lower dose of the extract and also with 
diazepam.  
 
Table 2: Effect of N. oleander (NO) flower extract 
on pentylenetetrazol (PTZ)-induced seizures in 










Vehicle (control) 1.02 ± 0.11 28.9 ± 0.2 
Diazepam 0 ± 0
†
 0 ± 0 
†
 
NO (100mg/kg) 4.99 ± 0.17
#
 7.0 ± 0.1
#
 
NO (200mg/kg) 1.60 ± 0.13
*




P < 0.001;  
#
p  < 0.01;  
*
p < 0.05 
 
Effect of extract on maximal electroshock 
convulsions (MEC) 
 
As Table 3 indicates, the higher dose of the 
extract (200 mg/kg) was more effective than 
the lower dose in lowering MEC. However, 
while the lower dose failed to provide 
protection against convulsion, the higher 
dose provided 60 % protection, compared 
with 100 % for the reference standard, 
diazepam.  
 
Table 3: Effect of Nerium oleander (NO) flower 
extract on maximal electroshock convulsions 








































































14.8±1.0 10/10 0 
Diazepam (2) 0±0
†










 04/10 60 
†
P < 0.001;  
#
p < 0.01;  
*




Acute toxicity data indicate that the maximum 
tolerable dose of N. oleander flower extract in 
mice is 2000 mg/kg body weight, suggesting 
that the extract is not highly toxic.  
 
The reduction in locomotor activity following 
the administration of the extract implies that it 
exerted a depressive effect on the CNS [9]. It 
has been established that increase in the 
concentration of gamma-amino butyric acid 
(GABA) may lead to CNS depressant effect 
[10]. This led to further exploration of the 
effect of the extract on activities responsible 
for increase in GABA concentration, such as 
potentiation of hexobarbital-induced 
hypnosis, motor coordination, anticonvulsant 
activity. The fact that extract activity was 
potentiated by pentobarbitone in induced 
hypnosis suggest a GABA-mediated effect on 
the CNS since CNS depressants extend 
barbiturate sleeping time [11].  
 
It is known that sedative-hypnotic drugs 
induce their effect on the Gabaergic system 
in the brain and inhibition of neuronal output 
could be facilitated by GABA (an inhibitory 
neurotransmitter) release [12]. Loss of 
righting reflex induced by phenobarbital is 
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potentiated by GABA agonist (muscimol and 
4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol 
(THIP) and inhibited by GABA antagonist 
(bicucullin); the activation of GABA receptor 
partially mediates the sleep response [13]. It 
is thus plausible to assert that the sedative 
effect of the extract is due to the facilitation of 
GABAergic transmission. The findings in 
respect of the extract of N. oleander flower 
are in agreement with those reported for 
some other plants (Rauwolfia canescens [14] 
and Carissa edulis [15]). The fact that the 
extract had no effect on motor coordination 
also implies that it exerts significant CNS 
depressant effect through GABA receptor 
stimulation.  
 
The test on the anticonvulsant activity of the 
extract is in effect a measure of its 
stimulatory effect on GABA receptor. Two 
different anticonvulsant animal models were 
used: MES- and PTZ-induced convulsion 
models. The extract showed anticonvulsant 
activity in PTZ-induced convulsion model and 
the higher dose of the extract (200 mg/kg) 
was more effective than the lower dose in 
lowering MEC. PTZ-induced activation of T-
type Ca
2+
 channels of the thalamic region 
produces petit mal seizures [16]. Compounds 
that are effective in PTZ-induced seizure 
models are effective against petit mal type of 
epilepsy [17]. Petit mal seizures can also be 
prevented by drugs that enhance GABAA–
BZD receptor mediated neurotransmission 
such as benzodiazepines and 
phenobarbitone [18]. Protection against hind 
limb tonic extension also shows the capability 
of the extract to prevent seizure discharge 
within the brain stem seizure substrate [19], 
suggesting that the extract may be useful in 





On the basis of results obtained, the 
hydroalcohol extract of Nerium oleander 
flowers exhibited anticonvulsant activity 
against PTZ and MES in experimental animal 
models. Further fractionation of this extract, 
may yield antiepileptic drug(s). Also, the 
results further buttresses the pharmacological 
basis for the ethnomedicinal use of the plant 
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